PBTC-053: A Pediatric Brain Tumor Consortium Phase I/ II and Surgical Study of CX-4945 in Patients With Recurrent SHH Medulloblastoma
Phase of Trial: Phase I/II
Latest Information Update: 25 Sep 2019
Price : $35 *
At a glance
- Drugs Silmitasertib (Primary)
- Indications Medulloblastoma
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 26 Jul 2019 Status changed from not yet recruiting to recruiting.
- 03 Apr 2019 Status changed from planning to not yet recruiting.
- 19 Jun 2018 New trial record